Tesamorelin Side Effects: What Studies and Users Report
What FDA labels, clinical studies and people who use Tesamorelin report, how strong that evidence is, and what is still unknown.
Side effects reported in studies
Adverse reactions from the FDA label come first, then side effects reported in individual studies. Frequencies are quoted as the source gives them; animal results are labelled.
| Side effect | How common | Study type | Source |
|---|---|---|---|
| Most commonly reported adverse reactions | most common | FDA label | FDA label (Egrifta WR) |
| Diabetes (HbA1c 6.5% or higher) | 5% vs 1% (EGRIFTA vs placebo) | FDA label | FDA label (Egrifta WR) |
| Injection site reaction | 17% vs 6% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Arthralgia | 13% vs 11% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Pain in extremity | 6% vs 5% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Myalgia | 6% vs 2% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Peripheral edema | 6% vs 2% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Paresthesia | 5% vs 2% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Hypoesthesia | 4% vs 2% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Rash | 4% vs 2% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Dyspepsia | 2% vs 1% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Musculoskeletal pain | 2% vs 1% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Pain | 2% vs 1% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Pruritus | 2% vs 1% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Vomiting | 3% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Musculoskeletal stiffness | 2% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Blood creatine phosphokinase increased | 1% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Carpal tunnel syndrome | 1% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Joint swelling | 1% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Muscle strain | 1% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Night sweats | 1% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Palpitations | 1% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta WR) |
| Diabetes (HbA1c 6.5% or higher) | 5% vs 1% (EGRIFTA vs placebo) | FDA label | FDA label (Egrifta SV) |
| Injection site reaction | 17% vs 6% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Arthralgia | 13% vs 11% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Pain in extremity | 6% vs 5% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Myalgia | 6% vs 2% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Peripheral edema | 6% vs 2% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Paresthesia | 5% vs 2% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Hypoesthesia | 4% vs 2% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Rash | 4% vs 2% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Dyspepsia | 2% vs 1% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Musculoskeletal pain | 2% vs 1% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Pain | 2% vs 1% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Pruritus | 2% vs 1% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Vomiting | 3% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Musculoskeletal stiffness | 2% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Blood creatine phosphokinase increased | 1% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Carpal tunnel syndrome | 1% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
| Joint swelling | 1% vs 0% (EGRIFTA vs placebo, 26 weeks) | FDA label | FDA label (Egrifta SV) |
Showing the first 40 of 51 rows, strongest sources first.
Overall safety findings
What studies said about safety as a whole, without naming a specific effect.
| Finding | How common | Study type | Source |
|---|---|---|---|
| Adverse events“There were no serious adverse events or differences in adverse events between the groups.” | Frequency not stated | Human RCTn = 60 | The Journal of clinical endocrinology and metabolism 2012, PMID 23015655 |
| Adverse events | 68% tesamorelin vs 36% placebo | Human RCTn = 152 | Archives of neurology 2012, PMID 22869065 |
| Tolerability“The drug was well tolerated.” | Frequency not stated | Human RCTn = 404 | Journal of acquired immune deficiency syndromes 2010, PMID 20101189 |
| Withdrawal because of adverse event“Adverse events did not differ significantly between the two study groups, but more patients in the tesamorelin group withdrew from the study because of an adverse event.” | Frequency not stated | Human RCTn = 412 | The New England journal of medicine 2007, PMID 18057338 |
| Arthralgia | statistically significant (GH-axis drugs as a group) | Systematic reviewn = 1511 | HIV medicine 2011, PMID 21265979 |
| Oedema | statistically significant (GH-axis drugs as a group) | Systematic reviewn = 1511 | HIV medicine 2011, PMID 21265979 |
| Liver and kidney findings, anaemia and clinical chemistry changes (dogs) | reversible; dogs only | Animal · rat and dog (not a human result) | Basic & clinical pharmacology & toxicology 2007, PMID 17214611 |
What users report
Side effects people describe from their own use of Tesamorelin, quoted from 14 Reddit threads we read in r/Tesamorelin, r/Peptides and r/PeptideGuide (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.
| What people noticed | People reporting it | In their words |
|---|---|---|
| Joint or muscle aches | 10 | “My knees and hips started aching after a week” r/Tesamorelin, May 2026“I got hip pain for a week.” r/Tesamorelin, May 2026 |
| Trouble sleeping | 10 | “I take tesa nightly and it’s really fucked up my sleep my HRV my Rhr and my recovery” r/Tesamorelin, Jun 2026Also taking other compounds“but tesa fucked my sleep” r/Tesamorelin, Jun 2026 |
| Allergic reaction (hives, itching all over, swelling) | 10 | “my whole body was red and covered in hives like mosquito bites everywhere. Then my tongue started swelling, harder to breathe” r/Tesamorelin, Oct 2026“Chest turned bright red and my stomach broke out in a rash.” r/Tesamorelin, Oct 2026 |
| Water retention or puffiness | 9 | “Yes I got water weight retention weeks 3-4.” r/Tesamorelin, May 2026“I'm on week 2 and bloated” r/Tesamorelin, May 2026 |
| Numbness, tingling or carpal-tunnel-type pain in hands | 8 | “Over the last several weeks I’ve developed increasingly noticeable numbness/tingling in both hands” r/Tesamorelin, Aug 2026“started to wake up couple of times in the night with numbness in my fingers” r/Tesamorelin, Aug 2026 |
| Injection-site redness, itching or welts | 7 | “Would get some bad swelling from shots, would look like bug bites or get bad skin irritation.” r/Tesamorelin, Oct 2026“Previously I would get welts at injection sites that felt kinda itchy and hard for a few days under the skin.” r/Tesamorelin, Oct 2026 |
| Tiredness or lethargy | 5 | “Tesamorelin made me feel like hell every day, so tired and cranky like I hadn’t slept in days.” r/Peptides, Mar 2026“In both cases I was ABSOLUTELY EXHAUSTED all day every day for the first 2-3 weeks.” r/Tesamorelin, Jun 2026 |
| Racing heart or raised heart rate | 4 | “Skin flushing, heart racing, throat felt tight” r/Peptides, Mar 2026“Made my heart race” r/Peptides, Mar 2026 |
| Injection-site pain | 3 | “1mg still burns during and afterwards for about 1 hour afterwards.” r/Tesamorelin, Jun 2026“it’s always burned after pinning” r/Tesamorelin, Jun 2026 |
| Vivid dreams | 3 | “having incredible incredible vivid dreams” r/Tesamorelin, May 2026“weird uncomfortable dreams” r/Tesamorelin, Jun 2026 |
| Higher blood sugar | 2 | “Blood sugar was 110 i began. It was 144 (fasting) this morning.” r/Tesamorelin, May 2026“it started messing with my blood sugar” r/Tesamorelin, Jun 2026 |
| Brain fog | 1 | “Brain fog and feeling flat.” r/Tesamorelin, Jun 2026Also taking other compounds |
| Stomach upset | 1 | “I had a stomach issue too at first.” r/Tesamorelin, May 2026 |
| Headache | 1 | “The headache and aches would subside with advil then return immediately.” r/Tesamorelin, Jun 2026 |
| Fat loss in unwanted areas | 1 | “I’m starting to notice my boobs look like they’re losing fat too” r/Peptides, Aug 2026 |
3 people in the same threads said they noticed no side effects:
A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.
What is not known
- How common each effect is at the doses people use outside of studies.
- Effects that take longer to appear than the length of the published studies.
- How Tesamorelin interacts with other medicines and supplements.
- Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.
When to get medical help
This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.
What the Egrifta label forbids
The label lists four contraindications: disruption of the hypothalamic-pituitary axis, active malignancy, known hypersensitivity, and pregnancy.[1]
For pregnancy, the label reasons that modifying visceral adipose tissue offers no benefit and could result in fetal harm.[1]
Serious warnings in the label
The label lists increased risk of neoplasms: a preexisting malignancy should be inactive and its treatment complete before starting, and the drug should be discontinued if malignancy recurs.[1]
The label states that it stimulates GH production and increases serum IGF-1, a growth factor.[1]
The label says fluid retention may occur and may include edema, arthralgia and carpal tunnel syndrome.[1]
The label says glucose intolerance or diabetes mellitus may develop.[1]
Hypersensitivity reactions occurred in 4% of patients treated in clinical trials.[1]
What the HIV lipodystrophy trials reported
A large phase 3 trial found no significant difference in adverse events between arms, but more patients on tesamorelin withdrew because of an adverse event.[8]
In the 52-week extension, changes in glucose parameters were not clinically significant.[7]
A fatty-liver trial reported more localised injection-site complaints with tesamorelin, none judged serious.[3]
A recent meta-analysis of HIV lipodystrophy trials observed growth hormone-related adverse effects and higher discontinuation rates (RR2.25, p=0.06).[9]
Common questions
What are the side effects of Tesamorelin?
The FDA label lists most commonly reported adverse reactions, diabetes (hba1c 6.5% or higher), injection site reaction among others. The table on this page gives how often each happened and links each source.
What side effects do people who use Tesamorelin report?
In the 14 Reddit threads we read (11 Oct 2026), people most often described joint or muscle aches (10 people), trouble sleeping (10 people), allergic reaction (hives, itching all over, swelling) (10 people). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.
Is tesamorelin safe?
One trial abstract in HIV patients with abdominal fat describes the drug as well tolerated. The label's contraindications and warnings are listed above.[6]
Is Tesamorelin banned in sport?
Yes. Prohibited by WADA (S2.2.4). Tested athletes should not use it.
What are the Egrifta side effects?
The label's most commonly reported adverse reactions were hypersensitivity reactions, edema-related reactions, hyperglycemia and injection site reactions.[1]
Does tesamorelin cause cancer?
The Egrifta WR label lists an increased risk of neoplasms as a warning: the drug induces release of growth hormone, a known growth factor, and it should not be used in patients with active malignancy.[1]
Can tesamorelin cause a rash?
Yes, rash is one of the hypersensitivity reactions the Egrifta WR label names, alongside itching, redness, flushing and hives; such reactions occurred in 4% of patients treated in clinical trials.[1]
More on Tesamorelin
Sources
- 1EGRIFTA WR (TESAMORELIN) KIT [THERATECHNOLOGIES INC.]FDA label (Egrifta WR), DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 2EGRIFTA SV (TESAMORELIN) KIT [THERATECHNOLOGIES INC.]FDA label (Egrifta SV), DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 3Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.The lancet. HIV · 2019PMID 31611038Accessed 2 Oct 2026
- 4Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.The Journal of clinical endocrinology and metabolism · 2012PMID 23015655Accessed 2 Oct 2026
- 5Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.Archives of neurology · 2012PMID 22869065Accessed 2 Oct 2026
- 6Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.Journal of acquired immune deficiency syndromes (1999) · 2010PMID 20101189Accessed 2 Oct 2026
- 7Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation.AIDS (London, England) · 2008PMID 18690162Accessed 2 Oct 2026
- 8Metabolic effects of a growth hormone-releasing factor in patients with HIV.The New England journal of medicine · 2007PMID 18057338Accessed 2 Oct 2026
- 9Efficacy and Safety of Tesamorelin in People Living With HIV (PLWH) With Lipodystrophy: A Systematic Review and Meta-Analysis.Journal of the International Association of Providers of AIDS Care · 2026PMID 42538058Accessed 2 Oct 2026
- 10Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials.HIV medicine · 2011PMID 21265979Accessed 11 Oct 2026
- 11Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue.Basic & clinical pharmacology & toxicology · 2007PMID 17214611Accessed 11 Oct 2026
- 12Reddit thread in r/Tesamorelin (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 13Reddit thread in r/Tesamorelin (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 14Reddit thread in r/Tesamorelin (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 15Reddit thread in r/Tesamorelin (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 16Reddit thread in r/Tesamorelin (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 17Reddit thread in r/Tesamorelin (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 18Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 19Reddit thread in r/Tesamorelin (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 20Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 21Reddit thread in r/Tesamorelin (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
Found an error? Report a correction.